Home

TIMOTHY J BARBERICH

CIK 1120355 · Executive Chairman · last filed 2023-12-21

TIMOTHY J BARBERICH is an Executive Chairman who has filed 85 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing shows the insider bought $142.5K of TCRX on Dec 21, 2023. Across all open-market trades the lifetime net is −$33.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $187.3K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$187.3K

Companies

8

Total Filings

85

Lifetime Open-Market Net

-$33.24M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TCRX Director 99,969 $0.77 $76.8K $242.0K 5 2023-12-21
Korro Bio, Inc. (FREQ) Delisted Director 3,655 $14.98 $54.8K $0 5 2022-08-19
VSTM Director 18,167 $6.08 $110.5K $813.6K 13 2021-06-30
ROCKET PHARMACEUTICALS, INC. (ITEK) Delisted Director — — — $0 2 2017-06-21
HeartWare International, Inc. (HTWR) Delisted Director 0 — — $195.5K 17 2016-08-24
Eledon Pharmaceuticals, Inc. (TKAI) Delisted Director 13,453 — — $0 3 2016-06-16
BIOSPHERE MEDICAL INC (BSMD) Delisted Director 0 — — $0 6 2010-09-10
SEPRACOR INC /DE/ (SEPR) Delisted Director 526,598 — — -$34.49M 29 2009-10-19

Recent Filings

85 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-12-21 TCRX Buy (P) +29,147 $142.5K EDGAR
2023-06-15 TCRX Grant (A) — $0 EDGAR
2023-06-06 TCRX Buy (P) +37,880 $99.6K EDGAR
2022-08-19 Korro Bio, Inc. (FREQ) Delisted Mixed — $0 EDGAR
2022-06-23 Korro Bio, Inc. (FREQ) Delisted Grant (A) — $0 EDGAR
2022-06-03 TCRX Grant (A) — $0 EDGAR
2021-07-22 TCRX Conv (C) +33,259 $0 EDGAR
2021-06-30 VSTM Grant (A) — $0 EDGAR
2021-06-21 Korro Bio, Inc. (FREQ) Delisted Grant (A) — $0 EDGAR
2020-12-07 VSTM Buy (P) +50,000 $108.5K EDGAR
Showing 1–10 of 85
Page 1 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.